RYTHM (RYM) Stock Price, News & Analysis

Company Overview

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

Key Stats

• Today's Range: $22.00 to $26.31
• 50-Day Range: $18.12 to $28.37
• 52-Week Range: $14.00 to $53.65
• Volume: 18,950 shs
• Average Volume: 15,443 shs
• Market Capitalization: $55.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

RYTHM Stock Analysis - MarketRank™

RYTHM scored higher than 20% of companies evaluated by MarketBeat, and ranked 848th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

RYTHM has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

RYTHM has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of RYTHM is -1.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of RYTHM is -1.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

RYTHM has a P/B Ratio of 4.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.28% of the float of RYTHM has been sold short.

Short Interest Ratio / Days to Cover

RYTHM has a short interest ratio ("days to cover") of 2.02, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in RYTHM has recently decreased by 12.71%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

RYTHM does not currently pay a dividend.

Dividend Growth

RYTHM does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.75

News Sentiment

RYTHM has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for RYTHM this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added RYTHM to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, RYTHM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $189,670.00 in company stock.

Percentage Held by Insiders

3.48% of the stock of RYTHM is held by insiders.

Percentage Held by Institutions

5.98% of the stock of RYTHM is held by institutions.

Company Calendar

• Today: 8/04/2026
• Last Earnings: 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:RYM
• CIK: 1800637
• Web: N/A
• Phone: (855) 420-0020
• Fax: N/A
• Employees: 140
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($14.36)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$33.26 million
• Net Margins: -38.99%
• Pretax Margin: -123.66%
• Return on Equity: -56.12%
• Return on Assets: -11.02%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.51
• Quick Ratio: 0.48

Sales & Book Value

• Annual Sales: $17.28 million
• Price / Sales: 3.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.06 per share
• Price / Book: 4.20

Miscellaneous

• Outstanding Shares: 2,180,000
• Free Float: 2,103,000
• Market Cap: $55.46 million
• Optionable: N/A
• Beta: 9.47